Compare Comcast Corporation (CMCSA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Comcast Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Comcast Corporation trades at $25.42 (market cap $91.02B), while Zimmer Biomet Holdings Inc trades at $97.03 (market cap $18.55B). The key difference: Comcast Corporation is far larger — about 4.9× Zimmer Biomet Holdings Inc's market cap, and Comcast Corporation pays the higher dividend (5.15%). Which is the better fit depends on your goals.
| CMCSA | ZBH | |
|---|---|---|
Market Cap | $91.02B | $18.55B |
Sector | Media | Health |
52-Week High | $32.50 | $107.71 |
52-Week Low | $21.92 | $79.58 |
Enterprise Value | $173.74B | $25.61B |
Dividend Yield | 5.15% | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Comcast (CMCSA) trades at $25.35, up 0.6% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.04 versus $0.97 expected, driven by wireless growth and Peacock profitability. Recent news highlights expansion of high-speed internet services and strategic initiatives like the NBCUniversal spinoff. Fundamentals show robust cash flow generation, with 2025 operating cash flow at $33.64 billion, and attractive valuation metrics including a P/E of 8.22 and EV/EBITDA of 5.09.
The outlook for CMCSA is positive, supported by analyst consensus with a $27.78 price target and 55.74% buy ratings. Investment opportunities include the potential upside from the NBCUniversal separation and sustained dividend payments. Key risks involve competitive pressures in broadband, theme park volatility, and integration challenges from corporate restructuring. The stock offers value with solid fundamentals but faces execution risks in a dynamic media landscape.
Zimmer Biomet (ZBH) trades at $97.9, up 0.12% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology. Key financials show a P/E of 23.6 and net income margin of 9.48%, while cash flow from operations improved to $1.70B in 2025.
The outlook is positive, with a consensus price target of $103.56 offering ~6% upside. Risks include competitive pressures and margin volatility, but consistent earnings beats and institutional accumulation support a constructive view for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Comcast Corporation
Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to roughly 61 million U.S. homes and businesses, or nearly half of the country. About 56% of the homes in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC broadcast network, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is the dominant television provider in the U.K. and has invested heavily in exclusive and proprietary content to build this position. The firm is also the largest pay-television provider in Italy and has a presence in Germany and Austria.
Read more on CMCSA →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
